Meningococcal carrier rate before and after hajj pilgrimage: Effect of single dose ciprofloxacin on carriage

Eastern Mediterranean Health Journal

Volumn 14, Issue 2, 2008, Pages 277-282

  Alborzi, A ^a   Oskoee, S ^a   Pourabbas, B ^a   Alborzi, S ^a   Astaneh, B ^a   Gooya, M M ^b   Kaviani, M J ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Director of Center for Communicable Diseases Control   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ADULT; ARTICLE; BACTERIUM CARRIER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CARRIER; DRUG EFFICACY; DRUG RESPONSE; ERADICATION THERAPY; FEMALE; HUMAN; INFECTION RISK; IRAN; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; RANDOMIZED CONTROLLED TRIAL; RELIGION; RISK REDUCTION; SINGLE DRUG DOSE; THROAT CULTURE;

ANTI-INFECTIVE AGENTS; CARRIER STATE; CHI-SQUARE DISTRIBUTION; CIPROFLOXACIN; FEMALE; HUMANS; IRAN; ISLAM; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; POPULATION SURVEILLANCE; RISK FACTORS; SAUDI ARABIA; SEROTYPING; TIME FACTORS; TRAVEL; TREATMENT OUTCOME;

EID: 45849087727     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. More PS et al. Group A meningococcal carriage in travelers returning from Saudi Arabia. Journal of the American Medical Association, 1988, 260(18):2686-9.
2. Al-Gahtani YM et al. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah, Saudi Arabia. Epidemiology and infection, 1995, 115:399-409.
3. Memish ZA. Meningococcal disease and travel. Clinical infectious diseases, 2002, 34:84-90.
4. Rosenstein NE et al. Meningococcal diseases. New England journal of medicine, 2001, 344:1378-88.
5. Wilder-Smith A, Barkham I, Chew SK. Absence of Neisseria meningitidis W135 electrophoretic Type 37 during Hajj, 2002. Emerging infectious diseases, 2003, 9(6):734-7.
6. Alborzi A et al. Bacterial etiology of active childhood meningitis in Shiraz, Iran: Incidence, clinical pictures, complications and antibiotic sensitivity pattern. Infectious diseases and tropical medicine, 2002, 7(18):26-31,
7. Pickering LK, ed. Red Book®. 2006 Report of the Committee on Infectious Diseases, 27th ed. Elk Grove Village, American Academy of Pediatrics, 2006:456.
8. Murray PR et al., eds. Manual of clinical microbiology, 8th ad. Washington DC, American Society for Microbiology, 2003: 601.
9. Nazer L, Rytel MW. Neisseria meningitidis serogroup Z as a cause of meningitis. Wisconsin medical journal, 1985, 84(8):16-7.
10. Wilder-Smith A et al. Acquisition of meningococcal carriage in Hajj pilgrims and transmission to their household contacts: prospective study. British medical journal, 2002, 325:365-6.
11. Gagneux SP et al. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. Journal of infectious diseases, 2002, 185:618-26.
12. Cuevas LE et al. Eradication of nasopharyngeal carrier of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampin. Journal of infectious diseases, 1995, 171(3):728-31.